1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Interventional Cardiology Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 9
3 Interventional Cardiology Market, United States 12
3.1 Interventional Cardiology Market, United States, Revenue ($m), 2015-2025 12
3.1.1 Cardiac Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 15
3.1.2 Coronary Stents Market, United States, Revenue ($m), by Segment, 2015-2025 17
3.1.3 Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), by Segment, 2015-2025 20
3.1.4 PTCA Balloon Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 22
3.2 Interventional Cardiology Market, United States, Volume (Units), 2015-2025 24
3.2.1 Cardiac Catheters Market, United States, Volume (Units), by Segment, 2015-2025 27
3.2.2 Coronary Stents Market, United States, Volume (Units), by Segment, 2015-2025 29
3.2.3 Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), by Segment, 2015-2025 32
3.2.4 PTCA Balloon Catheters Market, United States, Volume (Units), by Segment, 2015-2025 34
3.3 Interventional Cardiology Market, United States, Average Price ($) , 2015-2025 36
3.4 Interventional Cardiology Market, United States, Distribution Share by Revenue ($m), 2019 39
3.5 Interventional Cardiology Market, United States, Company Share by Revenue ($m), 2019 40
4 Overview of Key Companies in United States, Interventional Cardiology Market 42
4.1 Boston Scientific Corp 42
4.1.1 Company Overview 42
4.2 Abbott Laboratories 42
4.2.1 Company Overview 42
4.3 Medtronic Plc 42
4.3.1 Company Overview 42
4.4 Koninklijke Philips NV 43
4.4.1 Company Overview 43
4.5 Terumo Medical Corp 43
4.5.1 Company Overview 43
4.6 Cordis Corp 43
4.6.1 Company Overview 43
5 Interventional Cardiology Market Pipeline Products 44
6 Financial Deals Landscape 46
6.1 Acquisition 46
6.1.1 Viant Medical Acquires Meraqi Medical 46
6.1.2 Heraeus Medical Components to Acquire Via Biomedical 47
6.1.3 Siemens Healthineers Acquires Corindus Vascular Robotics 48
6.2 Debt Offerings 50
6.2.1 CryoLife Prices Private Placement of
4.250% Notes Due 2025 for USD100 Million 50
6.2.2 Boston Scientific Raises USD1.2 Billion in Public Offering of
2.65% Senior Notes due 2030 52
6.2.3 Boston Scientific Raises USD500 Million in Public Offering of
1.9% Senior Notes due 2025 54
6.2.4 Boston Scientific Raises USD999.2 Million in Public Offering of
0.625% Notes Due 2027 56
6.3 Equity Offerings 58
6.3.1 Cardiovascular Systems Prices Public Offering of Shares for USD125 Million 58
6.3.2 Cardiovascular Systems Announces Exercise of Over-Allotment Option of Public Offering of Shares for USD143.7 Million 60
6.3.3 Osprey Medical to Raise USD1.8 Million in Private Placement of CDI's 62
6.3.4 SurModics Plans to Raise up to USD200 Millon in Public Offering of Securities 63
6.3.5 Boston Scientific Raises USD1 Billion in Public Offering of Shares 64
6.3.6 Boston Scientific Raises USD1 Billion in Public Offering of
5.5% Mandatory Convertible Preferred Stock 66
6.3.7 AtriCure Prices Public Offering of Shares for USD175 Million 68
6.3.8 Precipio Files Registration Statement for Public Offering of Securities up to USD50 Million 70
6.3.9 Precipio Plans to Raise up to USD1.7 Million in Public Offering of Shares 71
6.3.10 Endologix Plans to Raise up to USD75 Million in Public Offering of Shares 72
6.4 Private Equity 73
6.4.1 Osprey Medical Raises USD6.2 Million in Entitlement Offer of CDI 73
6.5 Venture Financing 75
6.5.1 Efferent Labs to Raise USD3 Million in Venture Financing 75
6.5.2 HDL Therapeutics Raises USD3 Million in Venture Financing 76
6.5.3 Orchestra BioMed Raises USD34 Million in Series B-1 Financing 77
7 Recent Developments 79
7.1 Corporate Communications 79
7.1.1 Mar 03, 2020: Ocular Therapeutix Provides update on interim data from the OTX-TKI Phase 1 clinical trial at the Cowen 40th Annual Health Care Conference 79
7.1.2 Mar 03, 2020: Orchestra BioMed adds seasoned biotech executive Pamela Yanchik Connealy to Board of Directors 80
7.1.3 Feb 06, 2020: AngioDynamics appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer 81
7.1.4 Feb 03, 2020: Surmodics names Nusrath Sultana, MD, as Vice President, Clinical Affairs 81
7.1.5 Jan 10, 2020: Cardiva Medical appoints Jeri Hilleman to the company’s Board of Directors 82
7.1.6 Dec 23, 2019: Mayo Clinic names chief digital officer to lead transformative digital strategy, create Center for Digital Health 82
7.1.7 Dec 04, 2019: AtriCure names two industry veterans to Board of Directors 83
7.1.8 Dec 03, 2019: Dr. John Halamka named president of Mayo Clinic Platform 84
7.1.9 Nov 12, 2019: Cardiovascular Systems announces Stephen Stenbeck joins Board of Directors 84
7.1.10 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 85
7.1.11 Oct 22, 2019: AngioDynamics announces departure of CFO and appointment of interim CFO 86
7.1.12 Sep 24, 2019: Jaguar Health to host investor call to provide updates regarding development of Mytesi for the potential follow-on indication of cancer therapy-related diarrhea 86
7.1.13 Aug 28, 2019: Rose Kelly-Falls named global leader of procurement and supply chain for Cook Medical 87
7.1.14 Aug 19, 2019: Merit Medical announces appointment of Lynne N. Ward to its Board of Directors 87
7.1.15 Jul 31, 2019: AngioDynamics announces appointment of former Johnson & Johnson executive Karen Licitra to its Board of Directors 88
7.1.16 Jul 30, 2019: Certara introduces version
19.6 of Its D360 scientific informatics platform 88
7.1.17 Jul 25, 2019: Cardiovascular Systems announces former U.S. congressman Erik Paulsen joins board of directors 90
7.1.18 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health 90
7.1.19 Jul 03, 2019: Britta Lesaux appointed president & CEO Philips Canada 91
7.2 Financial Announcements 91
7.2.1 Feb 24, 2020: Merit Medical reports earnings for fourth quarter and year ended December 31, 2019, gives FY 2020 Guidance 91
7.2.2 Feb 20, 2020: Integer Holdings reports results for fourth quarter and full year 2019 93
7.2.3 Feb 19, 2020: Endologix reports fourth quarter and fiscal year 2019 financial results 94
7.2.4 Feb 13, 2020: CryoLife reports fourth quarter and full year 2019 financial results 95
7.2.5 Feb 06, 2020: Abiomed announces Q3 FY 2020 revenue of $222 million and
31.7% operating margin 96
7.2.6 Feb 05, 2020: Boston Scientific announces results for fourth quarter and full year 2019 97
7.2.7 Feb 05, 2020: Surmodics reports first quarter Fiscal 2020 results 99
7.2.8 Jan 28, 2020: Beckman Coulter's Access PCT Procalcitonin Assay receives U.S. FDA 510(k) clearance 100
7.2.9 Jan 14, 2020: Boston Scientific announces preliminary unaudited sales for the fourth quarter and full year 2019 101
7.2.10 Jan 13, 2020: Abiomed announces preliminary Q3 FY 2020 revenue of $222 million, up 10% over prior year 102
7.2.11 Jan 07, 2020: AngioDynamics reports fiscal 2020 second quarter financial results 103
7.2.12 Dec 20, 2019: Osprey Medical: Fourth Quarter Update 104
7.2.13 Nov 06, 2019: Endologix reports third quarter 2019 financial results 105
7.2.14 Oct 31, 2019: Abiomed announces Q2 FY 2020 revenue of $205 million and
29.4% operating margin 106
7.2.15 Oct 31, 2019: Surmodics reports fourth quarter fiscal 2019 results and issues fiscal 2020 revenue and EPS Guidance 107
7.2.16 Oct 30, 2019: Cue Biopharma announces upcoming scientific presentation at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting 108
7.2.17 Oct 30, 2019: CryoLife reports third quarter 2019 financial results 110
7.2.18 Oct 30, 2019: Merit Medical reports earnings for third quarter of 2019 111
7.2.19 Oct 30, 2019: AtriCure reports third quarter 2019 financial results 113
7.2.20 Oct 29, 2019: Cardiovascular Systems reports fiscal 2020 first-quarter financial results 114
7.2.21 Oct 29, 2019: Osprey Medical: 48% increase in DyeVert third quarter unit sales 116
7.2.22 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 117
7.2.23 Oct 03, 2019: AngioDynamics reports fiscal 2020 first quarter financial results 119
7.2.24 Sep 25, 2019: Katerzia, the first and only amlodipine oral suspension, 1 mg/mL, is now commercially available for pediatric patients 6 years of age and older 120
7.2.25 Sep 02, 2019: Quantum Genomics Announces Positive FDA Feedback on Phase III Program Design of Firibastat in Resistant Arterial Hypertension 122
7.2.26 Aug 14, 2019: Osprey Medical: First half revenues increase 54% to US$1.8 million 123
7.2.27 Aug 08, 2019: Corindus reports second quarter 2019 results 124
7.2.28 Aug 08, 2019: Endologix reports second quarter 2019 financial results 125
7.2.29 Aug 07, 2019: Neovasc announces second quarter 2019 financial results 125
7.2.30 Aug 06, 2019: Cardiovascular Systems reports fiscal 2019 fourth-quarter financial results 128
7.2.31 Aug 01, 2019: Abiomed announces Q1 FY 2020 revenue of $208 million and
29.2% operating margin 130
7.2.32 Aug 01, 2019: Integer Holdings reports second quarter 2019 results 132
7.2.33 Jul 31, 2019: Surmodics reports third quarter fiscal 2019 results and raises fiscal 2019 revenue and EPS guidance 132
7.2.34 Jul 30, 2019: AtriCure reports second quarter 2019 Financial Results 133
7.2.35 Jul 30, 2019: CryoLife reports second quarter 2019 financial results 133
7.2.36 Jul 25, 2019: Merit Medical reports earnings for second quarter of 2019 134
7.2.37 Jul 24, 2019: Boston Scientific announces results for second quarter 2019 137
7.2.38 Jul 10, 2019: AngioDynamics reports fiscal 2019 fourth quarter and full-year financial results 138
7.3 Government and Public Interest 139
7.3.1 Jan 27, 2020: Merit Medical issues statement regarding director nominations from starboard 139
7.4 Legal And Regulatory 140
7.4.1 Jan 13, 2020: Cortexyme announces the initiation of an open-label extension study for the GAIN Trial of COR388 in Alzheimer’s disease 140
7.4.2 Nov 18, 2019: Integer updates 2019 guidance following customer chapter 11 filing, no change in prior view of 2020 sales outlook 141
7.4.3 Aug 07, 2019: Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed against Abiomed and encourages Abiomed investors to contact the firm 142
7.5 Other Significant Developments 142
7.5.1 Apr 14, 2020: BioCardia announces litigation financing in the case captioned Boston Scientific 142
7.5.2 Mar 04, 2020: CytoDyn treats first patient with Leronlimab in Phase 2 trial for GvHD under modified trial protocol 143
7.5.3 Mar 04, 2020: Neovasc updates investors at SVB Leerink 9th Annual Global Healthcare Conference 145
7.5.4 Dec 20, 2019: Cook Medical applauds congressional action to repeal the medical device excise tax 146
7.5.5 Nov 14, 2019: Precipio wins $750,000 Pharma Project 146
7.5.6 Nov 12, 2019: Integer announces commitments to reprice and extend maturity of its revolving credit facility and term Loan A; launches term Loan B repricing 146
7.5.7 Aug 28, 2019: Boston Scientific Celebrates 15th Anniversary in Costa Rica 146
7.5.8 Aug 13, 2019: Precipio Pathology sales metrics demonstrate continuous improvement in Q2 2019 147
7.5.9 Jul 22, 2019: Precipio: Global expansion efforts begin yielding results 148
7.5.10 Jul 15, 2019: Osprey Medical: 64% increase in DyeVert second quarter unit sales 148
7.5.11 Jul 10, 2019: Medtronic announces the early results of its cash tender offers for up to $5.525 billion of certain outstanding debt securities 150
7.6 Product News 151
7.6.1 Nov 19, 2019: Orchestra BioMed to present at the Canaccord Genuity MedTech and Diagnostics Forum and the 31st Annual Piper Jaffray Healthcare Conference 151
7.7 Strategy And Business Planning 151
7.7.1 Jun 25, 2020: Integer Opens New Innovative Ireland Research and Development Facility 151
7.7.2 Feb 20, 2020: Integer acquires Israel-based medical device firm Inomec 152
7.7.3 Jan 15, 2020: Merit milestones: facilities in Galway and Tijuana reach 1,000 employees 152
7.7.4 Oct 15, 2019: Sanofi opens digital manufacturing facility in the US 153
7.7.5 Jul 19, 2019: Midatech announces safety results from first in human study for injectable MidaCore Gold nano particle diabetes vaccine programme – MTX102 153
8 Appendix 156
8.1 Research Methodology 157
8.1.1 Coverage 157
8.1.2 Secondary Research 157
8.1.3 Primary Research 158
8.1.4 Market Modeling and Forecasting 159
8.1.5 Company Share Analysis 161
8.1.6 Distribution Share Analysis 161
8.1.7 Benchmarking 161
8.2 GlobalData Consulting 162
8.3 Contact Us 162
8.4 Disclaimer 163
